Blog Posts by Date: Jul 2018
Key Challenges Outreach Laboratories Are Facing
A strong laboratory outreach program is vital to hospital and health system success. A positive hospital outreach lab encounter helps drive admissions and referrals to the health system for additional services, and also provides the health system with valuable lab data, which contributes to help lower costs across the health system and support...
Visit XIFIN and Siemens Healthineers at AACC Annual Scientific Meeting
Recently at HIMSS 2018, XIFIN and Siemens Healthineers announced their partnership to help laboratories maximize reimbursement, making XIFIN the first partner to offer solutions for the clinical laboratory in the Siemens Healthineers Digital Ecosystem. Improving patient experience by optimizing diagnostic experience and delivering outcomes...
The Importance of Building Expect Pricing Into Your Revenue Forecast
In order to calculate the contractual allowance for third-party payors in legacy billing and revenue cycle management (RCM) systems, laboratories and other diagnostic providers had to calculate an estimate, based on an analysis of historical data at the payor group level (e.g. Medicare, Medicaid, Contracted Payors, etc.). In today’s environment...
What is MACRA? Is it Going Away?
Will quality reporting under MACRA change? Will it go away? Not likely. The reason: Medicare spend was 15% of total Federal spending in 2017 with payments totaling $702 billion and a projected growth in spend at 4.6% over the next ten years. With these projections the Medicare Hospital Insurance Trust is expected to be depleted in 2026, three...
Compliance is a Living Process: "Set it and Forget it" Can Lead to Trouble
Most of today’s laboratories and diagnostic providers are running on even slimmer profit margins. This is due in great part to lower reimbursements resulting from the Protecting Access to Medicare Act (PAMA) clinical laboratory fee schedule (CLFS) that came into effect in early 2018. In this environment there can sometimes be a tug-of-war between...
Keys to Countering PAMA
The second round of PAMA cuts are projected to cut individual test payment rates by up to 15%. With this in mind, now is the time that labs should be looking to market trends and strategies in order to prosper. At the NYSCLA Annual Meeting this year XIFIN CEO and Executive Chairman gave a presentation on strategies to offset PAMA cuts. Here are...